The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study

Table 2 Simulation cohort baseline characteristics

Characteristic	Value	Reference
Age (years)	64.2	[20]
Duration of diabetes (years)	4	[21]
Percentage male (%)	55.26	[20]
Clinical parameters
HbA1c (%)	8.16	[20]
SBP (mmHg)	141	[30]
Total cholesterol (mg/dl)	214.5	[30]
HDL-cholesterol (mg/dl)	42.9	[30]
LDL-cholesterol (mg/dl)	128.7	[30]
Triglycerides (mg/dl)	204.7	[30]
BMI (kg/m²)	30.1	[20]
Ethnicity
Proportion White (%)	82	Assumed*
Proportion Black (%)	9	Assumed*
Proportion Asian (%)	9	Assumed*
Comorbidities at baseline
Myocardial infarction (%)	8.2	[31]
Peripheral vascular disease (%)	4.5	[30]
Stroke (%)	6.6	[30]
Congestive heart failure (%)	22.8	[30]
Microalbuminuria (%)	0.7	[31]
End-stage renal disease (%)	1	[31]
Background diabetic retinopathy (%)	17.7	[31]
Neuropathy (%)	6.5	[31]

HbA1c -- glycosylated haemoglobin; SBP -- systolic blood pressure; HDL -- high-density lipoprotein; LDL -- low-density lipoprotein; BMI -- body mass index; * no data found and so assumed

ISSN: 1472-6823